99896-90-9
99896-90-9
Chemical Structure
AGDV
- CAS No.: 99896-90-9
- Formula:C14H24N4O7
- Molecular Weight:360.36
IUPAC Name: tert-butyl (2-bromo-5-cyclopropylthiophen-3-yl)carbamate
InChIKey: RNOHPFPLSXPVKT-LAEOZQHASA-N
SMILES: O=C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(O)=O)=O)=O)[C@H](C)N
Biological Activity: AGDV is the γ chain of fibrinogen. AGDV is critical for platelet aggregation[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AGDV | AGDV is the γ chain of fibrinogen. AGDV is critical for platelet aggregation. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lawrence JB, et al. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding. J Clin Invest. 1990 Nov;86(5):1715-22. [Content Brief]
- [2]. Plow EF, et al. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8057-61. [Content Brief]
